Harvard Bioscience Inc (HBIO) — Cash Flow Quality Index
Harvard Bioscience Inc (HBIO) has a Cash Flow Quality Index of 95.83x as of December 2024. Operating cash flow of $1.73 Million exceeds net income of $18.00K, indicating high earnings quality where cash backs reported profits. Explore HBIO cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Harvard Bioscience Inc Cash Flow Quality Index (2002–2014)
Historical Cash Flow Quality Index for Harvard Bioscience Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Harvard Bioscience Inc (HBIO) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Harvard Bioscience Inc (2002–2014)
Year-by-year earnings quality comparison for Harvard Bioscience Inc. For live market cap and the full company financial profile, see HBIO market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2014 | 1.85x | $4.35 Million | $2.35 Million | ▼ -45.7% |
| 2012 | 3.40x | $8.06 Million | $2.37 Million | ▲ +104.3% |
| 2011 | 1.67x | $6.35 Million | $3.81 Million | ▲ +157.6% |
| 2010 | 0.65x | $12.29 Million | $19.02 Million | ▼ -71.7% |
| 2009 | 2.28x | $16.51 Million | $7.23 Million | ▼ -58.5% |
| 2008 | 5.50x | $9.20 Million | $1.67 Million | ▲ +12.0% |
| 2004 | 4.91x | $11.44 Million | $2.33 Million | ▲ +931.6% |
| 2003 | 0.48x | $2.03 Million | $4.26 Million | ▼ -56.1% |
| 2002 | 1.08x | $799.46K | $737.33K | — |